Mirtazapina Sandoz Gmbh (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases norepinephrine release, and by antagonising 5‑HT2 and 5‑HT3 serotonin receptors. This dual action raises the levels of norepinephrine and serotonin in the brain, correcting the neurotransmitter imbalance that contributes to depression.

The appropriate dose of Mirtazapina Sandoz is determined by the prescribing clinician based on the individual’s clinical condition, response to therapy, age, liver function, and any concomitant medications. Dosage adjustments are made according to therapeutic response and tolerability.

Safety data for mirtazapine in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should discuss the risks and benefits with the patient before prescribing.

To order Mirtazapina Sandoz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapine belongs to the NaSSA class, which differs from selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants. It often provides stronger sedative effects and may increase appetite, making it useful for patients with insomnia or weight loss, whereas SSRIs are generally more activating and have a different side‑effect profile.

Mirtazapina Sandoz should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Mirtazapina Sandoz is taken orally, usually once daily in the evening. The tablet should be swallowed whole with water and not chewed or crushed, unless otherwise directed by a healthcare professional.

Serious risks include agranulocytosis, severe neutropenia, hepatotoxicity, Stevens‑Johnson syndrome, seizures, and the emergence or worsening of suicidal thoughts, particularly during the early weeks of treatment. Patients should be monitored closely for any of these events.

Mirtazapina Sandoz should be avoided in patients with known hypersensitivity to mirtazapine or any of its excipients, those currently taking monoamine oxidase inhibitors, and individuals with severe hepatic impairment unless the prescriber decides otherwise. Caution is also advised for the elderly and for patients with a history of bipolar disorder.